文献速递神经肌肉病

肌萎缩侧索硬化的全球患病率与发病率:一项系统综述

Global Prevalence and Incidence of Amyotrophic Lateral Sclerosis: A Systematic Review.
PubMed 文献 · Neurology · 2023-06-12

该系统综述检索了2010年1月1日至2021年5月6日发表的文献,纳入140篇基于人群的研究,其中85篇报告发病率、61篇报告患病率。发病率从厄瓜多尔的0.26/10万人年至日本的23.46/10万人年不等,时点患病率从伊朗的1.57/10万至美国的11.80/10万不等。全球报告估计值存在差异,登记系统并非到处可用,导致全球流行病学报告存在缺口。

要点

  • 发病率范围为0.26/10万人年(厄瓜多尔)至23.46/10万人年(日本)。
  • 时点患病率范围为1.57/10万(伊朗)至11.80/10万(美国)。
  • 全球报告估计值存在差异,登记系统并非普遍可用,造成报告缺口。

核心结论

  • 全球报告的肌萎缩侧索硬化发病率与患病率估计值存在差异。
  • 登记系统是量化疾病负担的重要工具,但并非到处可用,导致全球流行病学报告存在缺口。

研究设计与样本

  • 系统综述,检索MEDLINE、Embase、Global Health、PsycInfo、Cochrane Library和CINAHL,纳入2010年1月1日至2021年5月6日发表的基于人群且报告肌萎缩侧索硬化患病率、发病率和/或死亡率的研究。
  • 共生成6238篇文章,其中140篇被选入数据提取和质量评估,85篇报告发病率,61篇报告患病率。
  • 本综述在PROSPERO注册,注册号CRD42021250559。

主要发现

  • 发病率范围为0.26/10万人年(厄瓜多尔)至23.46/10万人年(日本)。
  • 时点患病率范围为1.57/10万(伊朗)至11.80/10万(美国)。
  • 许多文章从多个数据源识别肌萎缩侧索硬化病例。

局限性

  • 登记系统并非到处可用,导致全球肌萎缩侧索硬化流行病学报告存在缺口,表现为本综述报告发病率与患病率估计值的差异程度和质量不一。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Amyotrophic lateral sclerosis (ALS) is a rare neurodegenerative disorder affecting upper and lower motor neurons. Due to its rarity and rapidly progressive nature, studying the epidemiology of ALS is challenging, and a comprehensive picture of the global burden of this disease is lacking. The objective of this systematic review was to describe the global incidence and prevalence of ALS. METHODS: We searched MEDLINE, Embase, Global Health, PsycInfo, Cochrane Library, and CINAHL to identify articles published between January 1, 2010, and May 6, 2021. Studies that were population based and reported estimates of prevalence, incidence, and/or mortality of ALS were eligible for inclusion. This study focuses on the incidence and prevalence. Quality assessment was performed using a tool developed to evaluate methodology relevant to prevalence and incidence studies. This review was registered with PROSPERO, CRD42021250559. RESULTS: This search generated 6,238 articles, of which 140 were selected for data extraction and quality assessment. Of these, 85 articles reported on the incidence and 61 on the prevalence of ALS. Incidence ranged from 0.26 per 100,000 person-years in Ecuador to 23.46 per 100,000 person-years in Japan. Point prevalence ranged from 1.57 per 100,000 in Iran to 11.80 per 100,000 in the United States. Many articles identified cases with ALS from multiple data sources. DISCUSSION: There is variation in reported incidence and prevalence estimates of ALS across the world. While registries are an important and powerful tool to quantify disease burden, such resources are not available everywhere. This results in gaps in reporting of the global epidemiology of ALS, as highlighted by the degree of variation (and quality) in estimates of incidence and prevalence reported in this review.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Wolfson C, Gauvin DE, Ishola F, et al. Global Prevalence and Incidence of Amyotrophic Lateral Sclerosis: A Systematic Review. Neurology. 2023. PMID: 37308302. doi:10.1212/WNL.0000000000207474

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。